Загрузка...
Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer
Synergism in action of tucatinib and trastumab is reported in breast cancer management. However, its molecular basis is yet to be determined. In this context we attempted to provide an explanation at the molecular level by performing in silico experimentation and coupling its result with already ava...
Сохранить в:
| Опубликовано в: : | Indian J Clin Biochem |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer India
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7817741/ https://ncbi.nlm.nih.gov/pubmed/33505137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12291-019-00863-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|